ProteoMediX
VerifiedIdentification of novel biomarkers for the early detection of cancer.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$20—30m (Dealroom.co estimates Aug 2018.)
Company register number CHE-115.542.635
Schlieren Switzerland (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor | $0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Recent News about ProteoMediX
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.